Interestingly, regardless of the presence or absence of mutations in these genes in ESCC, their products (ERBB2 and MET) are often overexpressed in tumor tissues, indicating their vital carcinogenic role in ESCC [22]. This evidence concerns the gene ERBB2 and neoplasm.